The cleavage of the hemagglutinin protein of H5N2 avian influenza virus in yeast

Journal of Virological Methods

Volumn 146, Issue 1-2, 2007, Pages 293-297

  Wang, Chi Y ^a   Luo, Yu L ^a   Chen, Yu T ^a   Li, Shu K ^a   Lin, Chi H ^a   Hsieh, Yao C ^b   Liu, Hung J ^a  

^a NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^b Tainan Hsieh Livestock Disease Control Center   (Taiwan)

Author keywords

Avian influenza virus; Hemagglutinin protein; Methylotrophic yeast Pichia pastoris

Indexed keywords

MONOCLONAL ANTIBODY; VACCINE; VIRUS HEMAGGLUTININ;

AMINO ACID SEQUENCE; ANTIGENICITY; ARTICLE; COST; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; EUKARYOTE; GENE; GENOME; INFLUENZA VIRUS A H5N2; NONHUMAN; NUCLEOTIDE SEQUENCE; PICHIA PASTORIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; WESTERN BLOTTING; YEAST;

ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; BLOTTING, WESTERN; EPITOPES; GENES, VIRAL; GENETIC VECTORS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H5N2 SUBTYPE; PEPTIDE HYDROLASES; PICHIA; PLASMIDS; RECOMBINANT PROTEINS; RECOMBINATION, GENETIC; TRANSFORMATION, GENETIC;

AVES; AVIAN INFLUENZA VIRUS; EUKARYOTA; HUMAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE; PICHIA PASTORIS;

EID: 35648941596     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2007.07.012     Document Type: Article

References (44)

1. Amonsin A., Payungporn S., Theamboonlers A., Thanawongnuwech R., Suradhat S., Pariyothorn N., Tantilertcharoen R., Damrongwatanapokin S., Buranathai C., Chaisingh A., Songserm T., and Poovorawan Y. Genetic characterization of H5N1 influenza A virus isolated from zoo tigers in Thailand. Virology 34 (2006) 480-491
2. Bai G., Sakoda Y., Mweene A.S., Fujii N., Minakawa H., and Kida H. Improvement of a rapid diagnosis kit to detect either influenza A or B virus infection. J. Vet. Med. Sci. 68 (2006) 35-40
3. Barr K.A., Hopkins S.A., and Sreekrishna K. Protocol for efficient secretion of HAS developed from Pichia pastoris. Pharm. Eng. 12 (1992) 48-51
4. Bottcher E., Matrosovich T., Beyerle M., Klenk H., Garten W., and Matrosovich M. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J. Virol. 80 (2006) 9896-9898
5. Brierley, R.A., Davis, G.R., Hltz, G.C. 1994. Production of insulin-like growth factor 1 in methylotrophic yeast cells. United State Patent 5,324,639.
6. Brown E.G. Increased virulence of a mouse-adapted variant of influenza A/FM/1/47 virus is controlled by mutations in genome segments 4, 5, 7, and 8. J. Virol. 64 (1990) 4523-4533
7. Carroll S.M., and Paulson J.C. Differential infection of receptor-modified host cells by receptor-specific influenza viruses. Virus Res. 3 (1985) 165-179
8. Chan K.H., Maldeis N., Pope W., Yup A., Ozinskas A., Guill J., Seto W.H., Shortridge K.F., and Peiris J.S. Evaluation of the Directigen FluA + B test for rapid diagnosis of influenza virus type A and B infections. J. Clin. Microbiol. 40 (2002) 1675-1680
9. Choi Y.K., Nguyen T.D., Ozaki H., Webby R.J., Puthavathana P., Buranathal C., Chaisingh A., Auewarakul P., Hanh N.T.H., Ma S.K., Hui P.Y., Guan Y., Peiris J.S.M., and Webster R.G. Studies on H5N1 influenza virus infection of pigs by using viruses isolated in Vietnam and Thailand in 2004. J. Virol. 79 (2005) 10821-10825
10. Claas E.C., Osterhaus A.D.M.E., van Beek R., De Jong J.C., Rimmelzwaan G.F., Senne D.A., Krauss S., Shortridge K.F., and Webster R.G. Human influenza A (H5N1) virus related to a highly pathogenic avian influenza virus. Lancet 351 (1998) 472-477
11. Clare J.J., Romanos M.A., Rayment F.B., Rowedder J.E., Smith M.A., Payne M.M., Sreekrishna K., and Henwood C.A. Production of mouse epidermal growth factor in yeast: high-level secretion using Pichia pastoris containing multiple gene copies. Gene 105 (1991) 205-212
12. Daniels P.S., Jeffries S., Yates P., Schild G.C., Rogers G.N., Paulson J.C., Warton S.A., Douglas A.R., Skehel J.J., and Wiley D.C. The receptor-binding and membrane-fusion properties of influenza virus variants selected using anti-hemagglutinin monoclonal antibodies. EMBO J. 6 (1987) 1459-1465
13. Gao W., Soloff A.C., Lu X., Montecalvo A., Nguyen D.C., Matsuoka Y., Robbins P.D., Swayne D.E., Donis R.O., Katz J.M., Barratt-Boyes S.M., and Gambotto A. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J. Virol. 80 (2006) 1959-1964
14. Horimoto T., Takada A., Iwatsuki-Horimoto K., Hatta M., Goto H., and Kawaoka Y. Generation of Influenza A Viruses with chimeric (Type A/B) hemagglutinins. J. Virol. 77 (2003) 8031-8038
15. Hu Y.C., Luo Y.L., Ji W.T., Chulu J.L.C., Chang P.C., Wang C.Y., and Liu H.J. Dual expression and analysis of the HA protein of H5N2 avian influenza virus. J. Virol. Methods 135 (2006) 43-48
16. Ison M.G., and Hayden F.G. Therapeutic options for the management of influenza. Curr. Opin. Pharmacol. 1 (2001) 482-490
17. Kawaoka Y.S., Yamnikova T.M., Chambers D.K.L., and Webster R.G. Molecular characterization of a new hemagglutinin, subtype H14, of influenza A virus. Virology 179 (1990) 759-767
18. Keawcharoen J., Oraveerakul K., Kuiken T., Fouchier R.A.M., Amonsin A., Payungporn S., Noppornpanth S., Wattanodorn S., Theamboolers A., Tantilertcharoen R., Pattanarangsan R., Arya N., Ratanakorn P., Osterhaus A.D.M.E., and Poovorawan Y. Avian influenza H5N1 in tigers and leopards. Emerg. Infect. Dis. 10 (2004) 2189-2191
19. Kisselev A.F., Garcia-Calvo M., Overkleeft H.S., Peterson E., Pennington M.W., Ploegh H.L., Thornberry N.A., and Goldberg A.L. The caspase-like sites of proteasomes, their substrates specificity, new inhibitors and substrates, and allosteric interactions with the trpsin-like sites. J. Biol. Chem. 278 (2003) 35869-35877
20. Klenk H.D., and Garten W. Host cell proteases controlling virus pathogenicity. Trends Microbiol. 2 (1994) 39-43
21. Kodihalli S., Haynes J.R., Robinson H.L., and Webster R.G. Cross-protection among lethal H5N2 influenza virus induced by DNA vaccine to the hemagglutinin. J. Virol. 71 (1997) 3391-3396
22. Li Z., Mueller S.N., Ye L., Bu Z., Yang C., Ahmed R., and Steinhauer D.A. Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity. J. Virol. 79 (2005) 10003-10012
23. Moore C., Hibbitts S., Owen N., Corden S.A., Harrison G., Fox J., Gelder C., and Westmoreland D. Development and evaluation of a real-time nucleic acid sequence based amplification assay for rapid detection of influenza A. J. Med. Virol. 74 (2004) 619-628
24. Morsy J., Garten W., and Rott R. Activation of an influenza virus A/Turkey/Oregon/71 HA insertion variant by the subtilisin-like endoprotease furin. Virology 202 (1994) 988-991
25. Nicholson K.G., Colegate A.E., Podda A., Stephenson I., Wood J., Ypma E., and Zambon M.C. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomized trial of two potential vaccines against H5N1 influenza. Lancet 357 (2001) 1937-1943
26. Rimmelzwaan G.F., van Riel D., Baars M., Bestebroer T.M., van Amerongen G., Fouchier R.A.M., Osterhaus A.D.M., and Kuiken T. Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am. J. Pathol. 168 (2006) 176-183
27. Scholtissek C., Vallbracht A., Flehmig B., and Rott R. Correlation of pathogenicity and gene constellation of influenza A viruses. II. Highly neurovirulent recombinants derived from non-neurovirulent or weakly neurovirulent parent virus strains. Virology 95 (1979) 492-500
28. Siegel, R.S., Bukholz, R.G., Thill, G.P., Wondrack, L.M. 1990. Production of epidermal growth factor in methylotropic yeasts. International Patent Application, Publ. No. WO 90/10697.
29. Skehel J.J., and Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69 (2000) 531-569
30. Songserm T., Amonsin A., Jam-On R., Sae-Heng N., Meemak N., Pariyothorn N., Payngporn S., Theamboonlers A., and Poovorawan Y. Avian influenza H5N1 in naturally infected domestic cat. Emerg. Infect. Dis. 12 (2006) 681-683
31. Sreekrishna K. Strategies for optimizing protein expression and secretion in the methylotrophic yeast Pichia pastoris. In: Baltz R.H., Hegeman G.D., and Skatrud P.L. (Eds). Industrial Microorganisms: Basic and Applied Molecular Genetics (1993), American Society of Microbiology, Washington, DC 119-126
32. Sreekrishna K., Brankamp R.G., Kropp K.E., Blankenship D.T., Tsay J., Smith P.L., Wierschke J.D., Subramaniam A., and Birkenberger L.A. Strategies for optimal synthesis and secretion of heterologous proteins in the methylotrophic yeast Pichia pastoris. Gene 190 (1997) 55-62
33. Steinhauer D.A. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 258 (1999) 1-20
34. Stephenson I., Nicholson K.G., Wood J.M., Zambon M.C., and Katz J.M. Confronting the avian influenza threat: vaccine development for a potential pandemic. Lancet Infect. Dis. 4 (2004) 499-509
35. Stieneke-Grober A., Vey M., Angliker H., Shaw E., Thomas G., Roberts C., Klenk H.D., and Garten W. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J. 11 (1992) 2407-2414
36. Subbarao K., Klimov A., Katz J., Regnery H., Lim W., Hall H., Perdue M., Swayne D., Bender C., Huang J., Hemphill M., Rowe T., Shaw M., Xu X., Fukuda K., and Cox N.J. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279 (1998) 393-396
37. Tang D.G., Chung Y.C., Lai Y.K., Lai C.W., Liu H.J., and Hu Y.C. Display of avian influenza virus hemagglutinin on baculovirus envelope: effect of cytoplasmic domain on virus properties and potentials as vaccine. Mol. Ther. 15 5 (2007) 989-996
38. Treanor J.J., Wilkinson B.E., Masseoud F., Hu-Primmer J., Battaglia R., O'Brien D., Wolff M., Rabinorich G., Blackwelder W., and Katz J.M. Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. Vaccine 19 (2001) 1732-1737
39. Webby R.J., Perez D.R., Coleman J.S., Guan Y., Knight J.H., Govorkova E.A., McClain-Moss L.R., Peris J.S., Rehg J.E., Tuomanen E.I., and Webster R.G. Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet 363 (2004) 1099-1103
40. Webster R.G. Predictions for future human influenza pandemics. J. Infect. Dis. 176 Suppl. (1997) S14-S19
41. Webster R.G., Fynan E.F., Santro J.C., and Robinson H.L. Protection of ferrets against influenza challenge with a DNA vaccine to hemagglutinin. Vaccine 12 (1994) 1495-1498
42. Wood J.M., and Robertson J.S. From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza. Nat. Rev. Microbiol. 2 (2004) 842-847
43. Wood G.W., McCauley J.W., Bashiruddin J.B., and Alexander D.J. Deduced amino acid sequences at the hemagglutinin cleavage site of avian influenza A viruses of H5 and H7 subtypes. Arch. Virol. 130 (1993) 209-217
44. Wu P.C., Su H.Y., Lin D.T., Yen P.C., Lee L.H., and Liu H.J. Secreted expression of the VP2 protein of very virulent IBDV in Pichia pastoris. J. Virol. Methods 123 (2005) 221-225